Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M K Wolf

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
American Journal of Clinical Oncology|August 1, 1997
Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trialJ A Kish, M K Wolf, P F Schellhammer, et al.
Infection and Immunity|January 1, 1989
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775M K Wolf, G P Andrews, B D Tall, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Cultures of shiverer mutant cerebellum injected with normal oligodendrocytes make both normal and shiverer myelinS Billings-Gagliardi, A L Hall, G B Stanhope, et al.
FEMS Microbiology Letters|March 1, 1997
The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunitsM K Wolf, L A de Haan, F J Cassels, et al.
Brain : a Journal of Neurology|October 24, 2001
Towards the reconstruction of central nervous system white matter using neural precursor cellsM Mitome, H P Low, A van den Pol, et al.
Developmental Neuroscience|January 1, 1995
Jimpy 4J: a new X-linked mouse mutation producing severe CNS hypomyelinationS Billings-Gagliardi, D A Kirschner, N L Nadon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyR P Whitehead, M K Wolf, D L Solanki, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Journal of Clinical Microbiology|April 1, 1993
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle EastM K Wolf, D N Taylor, E C Boedeker, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group studyM E Marshall, M K Wolf, E D Crawford, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
American Journal of Clinical Oncology|August 1, 1997
Continuous-infusion 5-fluorouracil and cisplatin for advanced/recurrent transitional cell cancer of the bladder: a Southwest Oncology Group trialJ A Kish, M K Wolf, P F Schellhammer, et al.
Infection and Immunity|January 1, 1989
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775M K Wolf, G P Andrews, B D Tall, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1984
Cultures of shiverer mutant cerebellum injected with normal oligodendrocytes make both normal and shiverer myelinS Billings-Gagliardi, A L Hall, G B Stanhope, et al.
FEMS Microbiology Letters|March 1, 1997
The CS6 colonization factor of human enterotoxigenic Escherichia coli contains two heterologous major subunitsM K Wolf, L A de Haan, F J Cassels, et al.
Brain : a Journal of Neurology|October 24, 2001
Towards the reconstruction of central nervous system white matter using neural precursor cellsM Mitome, H P Low, A van den Pol, et al.
Developmental Neuroscience|January 1, 1995
Jimpy 4J: a new X-linked mouse mutation producing severe CNS hypomyelinationS Billings-Gagliardi, D A Kirschner, N L Nadon, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|August 1, 1995
A phase II trial of continuous-infusion recombinant interleukin-2 in patients with advanced renal cell carcinoma: a Southwest Oncology Group studyR P Whitehead, M K Wolf, D L Solanki, et al.
American Journal of Clinical Oncology|October 1, 1995
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group StudyM E Marshall, M K Wolf, E D Crawford, et al.
Journal of Clinical Microbiology|April 1, 1993
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle EastM K Wolf, D N Taylor, E C Boedeker, et al.
Investigational New Drugs|May 1, 1993
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group studyM E Marshall, M K Wolf, E D Crawford, et al.
Pageof 7